These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 16381004)
1. Calcitonin stimulates the secretion of urokinase-type plasminogen activator from prostate cancer cells: its possible implications on tumor cell invasion. Sabbisetti V; Chigurupati S; Thomas S; Shah G Int J Cancer; 2006 Jun; 118(11):2694-702. PubMed ID: 16381004 [TBL] [Abstract][Full Text] [Related]
2. Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action. Sabbisetti VS; Chirugupati S; Thomas S; Vaidya KS; Reardon D; Chiriva-Internati M; Iczkowski KA; Shah GV Int J Cancer; 2005 Nov; 117(4):551-60. PubMed ID: 15929083 [TBL] [Abstract][Full Text] [Related]
3. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling. Thomas S; Chiriva-Internati M; Shah GV Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556 [TBL] [Abstract][Full Text] [Related]
4. Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor. Thomas S; Chigurupati S; Anbalagan M; Shah G Mol Endocrinol; 2006 Aug; 20(8):1894-911. PubMed ID: 16574742 [TBL] [Abstract][Full Text] [Related]
5. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin. Yoshida E; Verrusio EN; Mihara H; Oh D; Kwaan HC Cancer Res; 1994 Jun; 54(12):3300-4. PubMed ID: 8205553 [TBL] [Abstract][Full Text] [Related]
7. A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells. Thakkar A; Aljameeli A; Thomas S; Shah GV Endocr Relat Cancer; 2016 Jan; 23(1):1-14. PubMed ID: 26432469 [TBL] [Abstract][Full Text] [Related]
8. Knock-down of calcitonin receptor expression induces apoptosis and growth arrest of prostate cancer cells. Thomas S; Muralidharan A; Shah GV Int J Oncol; 2007 Dec; 31(6):1425-37. PubMed ID: 17982669 [TBL] [Abstract][Full Text] [Related]
9. Regulation of urokinase production by androgens in human prostate cancer cells: effect on tumor growth and metastases in vivo. Xing RH; Rabbani SA Endocrinology; 1999 Sep; 140(9):4056-64. PubMed ID: 10465276 [TBL] [Abstract][Full Text] [Related]
10. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA). Hall CL; Tsan R; Mugnai G; Mazar A; Radinsky R; Pettaway CA Prostate; 2004 May; 59(2):167-76. PubMed ID: 15042617 [TBL] [Abstract][Full Text] [Related]
11. Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells. Ornstein DL; Zacharski LR Nutr Cancer; 2007; 58(1):115-26. PubMed ID: 17571974 [TBL] [Abstract][Full Text] [Related]
12. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. McGowen R; Biliran H; Sager R; Sheng S Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285 [TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits highly invasive prostate cancer cells. Lloyd FP; Slivova V; Valachovicova T; Sliva D Int J Oncol; 2003 Nov; 23(5):1277-83. PubMed ID: 14532966 [TBL] [Abstract][Full Text] [Related]
14. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion. Festuccia C; Giunciuglio D; Guerra F; Villanova I; Angelucci A; Manduca P; Teti A; Albini A; Bologna M Oncol Res; 1999; 11(1):17-31. PubMed ID: 10451028 [TBL] [Abstract][Full Text] [Related]
15. In vitro anti-invasive effects of N-(4-hydroxyphenyl)-retinamide on human prostatic adenocarcinoma. Kim JH; Tanabe T; Chodak GW; Rukstalis DB Anticancer Res; 1995; 15(4):1429-34. PubMed ID: 7654032 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion. Conn EM; Botkjaer KA; Kupriyanova TA; Andreasen PA; Deryugina EI; Quigley JP Am J Pathol; 2009 Oct; 175(4):1638-52. PubMed ID: 19729488 [TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator is necessary but not sufficient for prostate cancer cell invasion. Jarrard DF; Hansen NM; Patai B; Rukstalis DB Invasion Metastasis; 1995; 15(1-2):34-45. PubMed ID: 7672930 [TBL] [Abstract][Full Text] [Related]
19. Calcitonin is a prostate epithelium-derived growth stimulatory peptide. Chien J; Ren Y; Qing Wang Y; Bordelon W; Thompson E; Davis R; Rayford W; Shah G Mol Cell Endocrinol; 2001 Jul; 181(1-2):69-79. PubMed ID: 11476942 [TBL] [Abstract][Full Text] [Related]
20. Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways. Shah GV; Thomas S; Muralidharan A; Liu Y; Hermonat PL; Williams J; Chaudhary J Endocr Relat Cancer; 2008 Dec; 15(4):953-64. PubMed ID: 18784182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]